Amount

Results

Conclusion*

Standard commercial preterm formula group (% weight of total fatty acids):

12.8 LA, 1.4 ALA, no AA or DHA

Supplemented preterm formula group

(% weight of total fatty acids):

12.10 LA, 1.50 ALA, 0.49 AA, 0.35 DHA

At 14 days postpartum, infants in the supplemented formula group had significantly higher hematocrit (L/L) concentrations compared to those in the human milk group (p<0.05).

At 14 days postpartum, infants in the human milk group had significantly higher monocytes compared to both the standard formula group and the supplemented formula group (p<0.05).

At 42 days postpartum, infants in the standard formula group had significantly higher T helper phenotypes and CD4/CD8 phenotypes compared to both the supplemented formula group and the human milk group (p<0.05).

At 42 days postpartum, infants in the standard formula group had significantly lower monocytes compared to the human milk group (p<0.05).

At 42 days postpartum, infants in the human milk group had significantly higher B cells compared to those in both formula groups (p<0.05).

At 42 days postpartum, infants in the standard formula group had significantly higher sIL-2R production compared to the supplemented formula group (p<0.05) and significantly lower IL-10 production compared to the human milk group (p<0.05).

No other reported results were found to be significant.

B



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement